SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Government agencies and non-profits at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

14 government agencies and non-profits are at SITC 2026 — 32 presentations on the program and 4 with a booth in the exhibit hall. Most represented: National Cancer Institute (17 on the program), U.S. Food and Drug Administration (9 on the program), National Institutes of Health (6 on the program). 9 of them have their own page in this guide. As of Nov 2, 2026.

All 661 organizations at SITC 2026 →

Research topic
Top represented
Showing 1–9 of 14 organizations
OrganizationSITC 2026 Attendance
Government & non-profit
US federal agency for cancer research and training, part of the National Institutes of Health.
Talk
Thu Nov 5
3:35pm–3:50pm
Talk
Thu Nov 5
2:35pm–2:45pm
Session
Fri Nov 6
8:00am–8:05am
Presidential Welcome
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm
Session
Fri Nov 6
3:55pm–5:30pm
Oral Abstract Session 2
  1. 3:58pm–4:13pmCTH-401: Allogeneic iPSC-derived CAR-NK cells for the treatment of ovarian cancerCartherics
  2. 4:13pm–4:28pmMyeloid-selective P-LNP enables in vivo engineering of GPC3-targeted CAR macrophages, resulting in robust tumor control and antitumor macrophage reprogrammingUnited Immunity
  3. 4:28pm–4:43pmPTPN22 editing enhances CAR-NK cell persistence and antitumor activity under tumor-associated inflammatory stressChonnam National University
  4. 4:43pm–4:58pmCD4+ T cell-intrinsic IL-12 signaling mediates inflammatory tumor control with reduced toxicityFred Hutchinson Cancer Center
  5. 4:58pm–5:13pmAdoptive transfer of T cells engineered with mutant p53-specific TCRs for the treatment of metastatic solid epithelial cancers: interim report of ongoing phase II clinical trialNational Cancer Institute
  6. 5:13pm–5:28pmMacrophage-derived lipid transfer enables metabolic buffering and chemotherapy resistance in glioblastomaMayo Clinic
Poster
Sat Nov 7
12–1:30pm
6:40–8:10pm
Session
Sun Nov 8
8:15am–9:40am
Presidential Session
  1. 8:20am–8:35amSlit2–Robo1/2 signaling orchestrates a lymphovascular–myeloid axis that limits T cell priming and drives immunotherapy resistanceNYU Langone Health
  2. 8:35am–8:50amDual targeting of GARP on tumor and regulatory T cells with bispecific T cell engagers for effective cancer immunotherapyThe Ohio State University
  3. 8:50am–9:00amExpert DiscussantUC San Diego
  4. 9:00am–9:15amCholesterol-Dependent Glycolytic Shunting Through the ABCA1–HMOX1 Axis Sustains Immunosuppressive Myeloid Fitness in GlioblastomaStanford University
  5. 9:15am–9:30amTargeting a CD36-Dependent Macrophage Immunometabolic Program Enhances PARP Inhibitor Response in BRCA-Associated TNBCBrigham and Women's Hospital
  6. 9:30am–9:40amExpert DisucussantUniversity of Pittsburgh
Government & non-profit
U.S. federal agency that regulates drugs, biologics and medical devices, including cancer immunotherapies.
Session
Wed Nov 4
2:10pm–2:55pm
Session
Wed Nov 4
3:10pm–3:55pm
Panel Discussion 2: Biomarker Discovery and Digital AI
Biomarkers · AI & data
Session
Wed Nov 4
4:10pm–4:55pm
Panel Discussion 3: Regulatory Framework for New IO Agents
Regulatory · New agents
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm
Government & non-profit
US federal medical research agency.
Poster
Sat Nov 7
12–1:30pm
6:40–8:10pm
Government & non-profit
Nonprofit that funds cancer immunotherapy research and clinical trials.
Session
Sun Nov 8
9:55am–10:30am
CRI William B. Coley Award Lecture
Cell therapy
  1. 9:55am–10:30amHarnessing NK Cells in Cancer TherapiesCentre d'Immunologie de Marseille-Luminy
Government & non-profit
Patient advocacy foundation supporting melanoma research, education and patients.
Government & non-profit
Non-profit professional society for cancer immunotherapy, host of this meeting and publisher of the Journal for ImmunoTherapy of Cancer.
Booth
Exhibiting at Booth 715
Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm
Government & non-profit
A nonprofit association supporting cancer care teams and improving cancer care delivery.
CC
Caring Cross
Gaithersburg, MD
Government & non-profit
A nonprofit developing approaches to make cell and gene therapies more accessible.
Government & non-profit
Federally supported research laboratory focused on cancer research and biomedical science.

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from government agencies and non-profits

Tell us what you sell and we’ll find the people at these government agencies and non-profits most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse SITC 2026 by

Exhibit hall

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction